Theranos Investor FOMO Is Due Diligence Lesson, Attys Say
Testimony in ex-Theranos CEO Elizabeth Holmes' criminal fraud trial has revealed that many investors who funded the beleaguered blood-testing company leading up to its $10 billion valuation appeared to be influenced...To view the full article, register now.
Already a subscriber? Click here to view full article